(Q35778250)

10 August 2017

0 references

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease (English)

1 reference

10 August 2017

0 references

1 reference

Kihwang Lee

3

0 references

Yoo-Ri Chung

object named as

Yoo-Ri Chung

2

0 references

Eun-So Lee

object named as

Eun-So Lee

5

0 references

author name string

Ji-Youn Park

1

1 reference

PubMed ID

26069144

10 August 2017

Ji Hun Song

4

1 reference

10 August 2017

1 July 2015

1 reference

10 August 2017

Yonsei Medical Journal

1 reference

10 August 2017

56

1 reference

10 August 2017

4

1 reference

10 August 2017

1158-1162

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

10 August 2017

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Therapy of ocular Behçet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

Ocular Behçet disease: current therapeutic approaches

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4479849

Influence of human recombinant interferon- 2a (rhIFN- 2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26069144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interferon-alpha 2b for refractory ocular Behçet's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26069144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26069144

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3349/YMJ.2015.56.4.1158

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PubMed ID

26069144